Ferro-Sequels (old formulation) and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with Ferro-Sequels (old formulation) (docusate / ferrous fumarate).
Ferrous Fumarate Food
Moderate Food Interaction
Consumer information for this interaction is not currently available.
ADJUST DOSING INTERVAL: Concomitant use of some oral medications may reduce the bioavailability of orally administered iron, and vice versa.
Food taken in conjunction with oral iron supplements may reduce the bioavailability of the iron. However, in many patients intolerable gastrointestinal side effects occur necessitating administration with food.
MANAGEMENT: Ideally, iron products should be taken on an empty stomach (i.e., at least 1 hour before or 2 hours after meals), but if this is not possible, administer with meals and monitor the patient more closely for a subtherapeutic effect. Some studies suggest administration of iron with ascorbic acid may enhance bioavailability. In addition, administration of oral iron products and some oral medications should be separated whenever the bioavailability of either agent may be decreased. Consult the product labeling for specific separation times and monitor clinical responses as appropriate.
Switch to professional interaction data
Ferro-Sequels (old formulation) drug interactions
There are 92 drug interactions with Ferro-Sequels (old formulation) (docusate / ferrous fumarate).
Ferro-Sequels (old formulation) disease interactions
There are 5 disease interactions with Ferro-Sequels (old formulation) (docusate / ferrous fumarate) which include:
- hemoglobin abnormalities
- inflammatory bowel disease
- intestinal obstruction disorders
- achlorhydria
- gastrointestinal irritation
More about Ferro-Sequels (old formulation) (docusate / ferrous fumarate)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.